|
1
|
Zhou X, Jing J, Peng J, Mao W, Zheng Y,
Wang D, Wang X, Liu Z and Zhang X: Expression and clinical
significance of galectin-3 in osteosarcoma. Gene. 546:403–407.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chou AJ, Gupta R, Bell MD, Riewe KO,
Meyers PA and Gorlick R: Inhaled lipid cisplatin (ILC) in the
treatment of patients with relapsed/progressive osteosarcoma
metastatic to the lung. Pediatr Blood Cancer. 60:580–586. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Grignani G, Palmerini E, Ferraresi V,
D'Ambrosio L, Bertulli R, Asaftei SD, Tamburini A, Pignochino Y,
Sangiolo D, Marchesi E, et al: Italian Sarcoma Group: Sorafenib and
everolimus for patients with unresectable high-grade osteosarcoma
progressing after standard treatment: A non-randomised phase 2
clinical trial. Lancet Oncol. 16:98–107. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fujiwara T, Katsuda T, Hagiwara K, Kosaka
N, Yoshioka Y, Takahashi RU, Takeshita F, Kubota D, Kondo T,
Ichikawa H, et al: Clinical relevance and therapeutic significance
of microRNA-133a expression profiles and functions in malignant
osteosarcoma-initiating cells. Stem Cells. 32:959–973. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang J, Yan YG, Wang C, Zhang SJ, Yu XH
and Wang WJ: MicroRNAs in osteosarcoma. Clin Chim Acta. 444:9–17.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ye Z, Jingzhong L, Yangbo L, Lei C and
Jiandong Y: Propofol inhibits proliferation and invasion of
osteosarcoma cells by regulation of microRNA-143 expression. Oncol
Res. 21:201–207. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Song J, Li Y and An RF: Identification of
early-onset preeclampsia-related genes and microRNAs by
bioinformatics approaches. Reprod Sci. 22:954–963. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang W, Han S and Sun K: Combined
analysis of gene expression, miRNA expression and DNA methylation
profiles of osteosarcoma. Oncol Rep. 37:1175–1181. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhou J, Zhang Y, Qi Y, Yu D, Shao Q and
Liang J: MicroRNA-152 inhibits tumor cell growth by directly
targeting RTKN in hepatocellular carcinoma. Oncol Rep.
37:1227–1234. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chang J, Yao M, Li Y, Zhao D, Hu S, Cui X,
Liu G, Shi Q, Wang Y and Yang Y: MicroRNAs for osteosarcoma in the
mouse: A meta-analysis. Oncotarget. 7:85650–85674. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sun Y, He N, Dong Y and Jiang C:
MiR-24-BIM-Smac/DIABLO axis controls the sensitivity to doxorubicin
treatment in osteosarcoma. Sci Rep. 6:342382016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kindrat I, Tryndyak V, de Conti A,
Shpyleva S, Mudalige TK, Kobets T, Erstenyuk AM, Beland FA and
Pogribny IP: MicroRNA-152-mediated dysregulation of hepatic
transferrin receptor 1 in liver carcinogenesis. Oncotarget.
7:1276–1287. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ding Y, Wang Y, Chen J, Hu Y, Cao Z, Ren P
and Zhang Y: p21 overexpression sensitizes osteosarcoma U2OS cells
to cisplatin via evoking caspase-3 and Bax/Bcl-2 cascade. Tumour
Biol. 35:3119–3123. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xu G, Kuang G, Jiang W, Jiang R and Jiang
D: Polydatin promotes apoptosis through upregulation the ratio of
Bax/Bcl-2 and inhibits proliferation by attenuating the β-catenin
signaling in human osteosarcoma cells. Am J Transl Res. 8:922–931.
2016.PubMed/NCBI
|
|
15
|
Cao YH, Li DG, Xu B, Wang MQ, Zhen N, Man
LX, Zhang YY and Chi M: A microRNA-152 that targets the phosphatase
and tensin homolog to inhibit low oxygen induced-apoptosis in human
brain microvascular endothelial cells. Genet Mol Res. 15:gmr7371.
2016. View Article : Google Scholar
|
|
16
|
Qian L, Cai C, Yuan P, Jeong SY, Yang X,
Dealmeida V, Ernst J, Costa M, Cohen SN and Wei W: Bidirectional
effect of Wnt signaling antagonist DKK1 on the modulation of
anthrax toxin uptake. Sci China Life Sci. 57:469–481. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lu J, Duan Y, Zhang M, Wu M and Wang Y:
Expression of Wnt3a, Wnt10b, β-catenin and DKK1 in periodontium
during orthodontic tooth movement in rats. Acta Odontol Scand.
74:217–223. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xu Y, Chen B, George SK and Liu B:
Downregulation of MicroRNA-152 contributes to high expression of
DKK1 in multiple myeloma. RNA Biol. 12:1314–1322. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu Y, Liu YZ, Zhang RX, Wang X, Meng ZJ,
Huang J, Wu K, Luo JY, Zuo GW, Chen L, et al: Oridonin inhibits the
proliferation of human osteosarcoma cells by suppressing
Wnt/β-catenin signaling. Int J Oncol. 45:795–803. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yi XJ, Zhao YH, Qiao LX, Jin CL, Tian J
and Li QS: Aberrant Wnt/β-catenin signaling and elevated expression
of stem cell proteins are associated with osteosarcoma side
population cells of high tumorigenicity. Mol Med Rep. 12:5042–5048.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Brun J, Dieudonné FX, Marty C, Müller J,
Schüle R, Patiño-García A, Lecanda F, Fromigué O and Marie PJ: FHL2
silencing reduces Wnt signaling and osteosarcoma tumorigenesis in
vitro and in vivo. PLoS One. 8:e550342013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Miao CG, Yang YY, He X, Huang C, Huang Y,
Qin D, Du CL and Li J: MicroRNA-152 modulates the canonical Wnt
pathway activation by targeting DNA methyltransferase 1 in
arthritic rat model. Biochimie. 106:149–156. 2014. View Article : Google Scholar : PubMed/NCBI
|
